CN102318777B - N-3 fatty acid enriched laying hen feed and production method thereof - Google Patents
N-3 fatty acid enriched laying hen feed and production method thereof Download PDFInfo
- Publication number
- CN102318777B CN102318777B CN2011103145969A CN201110314596A CN102318777B CN 102318777 B CN102318777 B CN 102318777B CN 2011103145969 A CN2011103145969 A CN 2011103145969A CN 201110314596 A CN201110314596 A CN 201110314596A CN 102318777 B CN102318777 B CN 102318777B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- acid
- cobastab
- feed
- white carbon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 24
- 235000020660 omega-3 fatty acid Nutrition 0.000 title abstract description 6
- 235000013601 eggs Nutrition 0.000 claims abstract description 69
- 240000006240 Linum usitatissimum Species 0.000 claims abstract description 25
- 235000004431 Linum usitatissimum Nutrition 0.000 claims abstract description 25
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 22
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 40
- 239000000203 mixture Substances 0.000 claims description 35
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 32
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 30
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 30
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 29
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 29
- 239000011575 calcium Substances 0.000 claims description 29
- 229910052791 calcium Inorganic materials 0.000 claims description 29
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 28
- 102000004190 Enzymes Human genes 0.000 claims description 28
- 108090000790 Enzymes Proteins 0.000 claims description 28
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 28
- 229910021536 Zeolite Inorganic materials 0.000 claims description 28
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 28
- 229940088598 enzyme Drugs 0.000 claims description 28
- 239000010457 zeolite Substances 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 27
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 25
- 229930182817 methionine Natural products 0.000 claims description 21
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 20
- 239000004472 Lysine Substances 0.000 claims description 20
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 20
- 229910052742 iron Inorganic materials 0.000 claims description 20
- 229910052698 phosphorus Inorganic materials 0.000 claims description 20
- 239000011574 phosphorus Substances 0.000 claims description 20
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 19
- 229910052802 copper Inorganic materials 0.000 claims description 19
- 239000010949 copper Substances 0.000 claims description 19
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 17
- 229940088594 vitamin Drugs 0.000 claims description 17
- 229930003231 vitamin Natural products 0.000 claims description 17
- 235000013343 vitamin Nutrition 0.000 claims description 17
- 239000011782 vitamin Substances 0.000 claims description 17
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 17
- 229930003427 Vitamin E Natural products 0.000 claims description 16
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 16
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 16
- 239000011707 mineral Substances 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 16
- 235000019165 vitamin E Nutrition 0.000 claims description 16
- 229940046009 vitamin E Drugs 0.000 claims description 16
- 239000011709 vitamin E Substances 0.000 claims description 16
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 15
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 15
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 15
- 150000001413 amino acids Chemical class 0.000 claims description 15
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 15
- 229960001231 choline Drugs 0.000 claims description 15
- 229960000304 folic acid Drugs 0.000 claims description 15
- 235000019152 folic acid Nutrition 0.000 claims description 15
- 239000011724 folic acid Substances 0.000 claims description 15
- 229940055726 pantothenic acid Drugs 0.000 claims description 15
- 235000019161 pantothenic acid Nutrition 0.000 claims description 15
- 239000011713 pantothenic acid Substances 0.000 claims description 15
- 229910052711 selenium Inorganic materials 0.000 claims description 15
- 239000011669 selenium Substances 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 15
- 239000011701 zinc Substances 0.000 claims description 15
- 229910052725 zinc Inorganic materials 0.000 claims description 15
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 14
- 125000001931 aliphatic group Chemical group 0.000 claims description 14
- 229960002685 biotin Drugs 0.000 claims description 14
- 235000020958 biotin Nutrition 0.000 claims description 14
- 239000011616 biotin Substances 0.000 claims description 14
- -1 compound amino acid Chemical class 0.000 claims description 14
- 229960003512 nicotinic acid Drugs 0.000 claims description 14
- 235000019192 riboflavin Nutrition 0.000 claims description 14
- 229960002477 riboflavin Drugs 0.000 claims description 14
- 239000002151 riboflavin Substances 0.000 claims description 14
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 13
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 13
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 13
- 235000019155 vitamin A Nutrition 0.000 claims description 13
- 239000011719 vitamin A Substances 0.000 claims description 13
- 229940045997 vitamin a Drugs 0.000 claims description 13
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 12
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 12
- 229930003316 Vitamin D Natural products 0.000 claims description 12
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 12
- 235000001968 nicotinic acid Nutrition 0.000 claims description 12
- 239000011664 nicotinic acid Substances 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- 235000019166 vitamin D Nutrition 0.000 claims description 12
- 239000011710 vitamin D Substances 0.000 claims description 12
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 12
- 229940046008 vitamin d Drugs 0.000 claims description 12
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 11
- 229930003448 Vitamin K Natural products 0.000 claims description 11
- 239000011777 magnesium Substances 0.000 claims description 11
- 229910052749 magnesium Inorganic materials 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 11
- 235000019168 vitamin K Nutrition 0.000 claims description 11
- 239000011712 vitamin K Substances 0.000 claims description 11
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 11
- 229940046010 vitamin k Drugs 0.000 claims description 11
- 108010011619 6-Phytase Proteins 0.000 claims description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 10
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 10
- 102000016943 Muramidase Human genes 0.000 claims description 10
- 108010014251 Muramidase Proteins 0.000 claims description 10
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 10
- 240000008042 Zea mays Species 0.000 claims description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
- 235000005822 corn Nutrition 0.000 claims description 10
- 239000011630 iodine Substances 0.000 claims description 10
- 229910052740 iodine Inorganic materials 0.000 claims description 10
- 235000010335 lysozyme Nutrition 0.000 claims description 10
- 229960000274 lysozyme Drugs 0.000 claims description 10
- 239000004325 lysozyme Substances 0.000 claims description 10
- 229910052748 manganese Inorganic materials 0.000 claims description 10
- 239000011572 manganese Substances 0.000 claims description 10
- 229940085127 phytase Drugs 0.000 claims description 10
- 235000019733 Fish meal Nutrition 0.000 claims description 9
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 9
- 239000002374 bone meal Substances 0.000 claims description 9
- 229940036811 bone meal Drugs 0.000 claims description 9
- 239000004467 fishmeal Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 235000019157 thiamine Nutrition 0.000 claims description 9
- 229960003495 thiamine Drugs 0.000 claims description 9
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 9
- 239000011721 thiamine Substances 0.000 claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- 241000276489 Merlangius merlangus Species 0.000 claims description 8
- 241000255789 Bombyx mori Species 0.000 claims description 7
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 7
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 7
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 7
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 7
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 7
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 7
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 7
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 7
- 240000000171 Crataegus monogyna Species 0.000 claims description 7
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 7
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 7
- 244000000626 Daucus carota Species 0.000 claims description 7
- 235000002767 Daucus carota Nutrition 0.000 claims description 7
- 244000068988 Glycine max Species 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 7
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 7
- 229940029982 garlic powder Drugs 0.000 claims description 7
- 235000015099 wheat brans Nutrition 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 22
- 210000002969 egg yolk Anatomy 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 18
- 238000012360 testing method Methods 0.000 abstract description 13
- 235000012000 cholesterol Nutrition 0.000 abstract description 10
- 230000009102 absorption Effects 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 7
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000001976 improved effect Effects 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 235000020235 chia seed Nutrition 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000029087 digestion Effects 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 description 30
- 241001465754 Metazoa Species 0.000 description 30
- 230000012010 growth Effects 0.000 description 23
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 20
- 235000001014 amino acid Nutrition 0.000 description 18
- 230000004060 metabolic process Effects 0.000 description 18
- 235000006109 methionine Nutrition 0.000 description 17
- 229960003284 iron Drugs 0.000 description 16
- 229940108928 copper Drugs 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 244000144977 poultry Species 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 235000010755 mineral Nutrition 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 235000018977 lysine Nutrition 0.000 description 12
- 229940091258 selenium supplement Drugs 0.000 description 11
- 108010000912 Egg Proteins Proteins 0.000 description 10
- 102000002322 Egg Proteins Human genes 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 10
- 102000019197 Superoxide Dismutase Human genes 0.000 description 8
- 108010012715 Superoxide dismutase Proteins 0.000 description 8
- 238000009395 breeding Methods 0.000 description 8
- 230000001488 breeding effect Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 230000012447 hatching Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 230000002950 deficient Effects 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- 210000003746 feather Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 206010053759 Growth retardation Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 210000003278 egg shell Anatomy 0.000 description 6
- 231100000001 growth retardation Toxicity 0.000 description 6
- 235000005152 nicotinamide Nutrition 0.000 description 6
- 239000011570 nicotinamide Substances 0.000 description 6
- 230000035790 physiological processes and functions Effects 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 244000144972 livestock Species 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 208000027219 Deficiency disease Diseases 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 235000019766 L-Lysine Nutrition 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 206010033799 Paralysis Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 210000003323 beak Anatomy 0.000 description 4
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 229960003966 nicotinamide Drugs 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 208000007442 rickets Diseases 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010006956 Calcium deficiency Diseases 0.000 description 3
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 230000011132 hemopoiesis Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 210000002303 tibia Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000004031 Carboxy-Lyases Human genes 0.000 description 2
- 108090000489 Carboxy-Lyases Proteins 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 239000004470 DL Methionine Substances 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 108010074860 Factor Xa Proteins 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 241000282849 Ruminantia Species 0.000 description 2
- 240000005481 Salvia hispanica Species 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 201000000839 Vitamin K Deficiency Bleeding Diseases 0.000 description 2
- 206010047634 Vitamin K deficiency Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 229910000323 aluminium silicate Inorganic materials 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000036750 egg laying performance Effects 0.000 description 2
- 230000008011 embryonic death Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000011790 ferrous sulphate Substances 0.000 description 2
- 235000003891 ferrous sulphate Nutrition 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- JMANVNJQNLATNU-UHFFFAOYSA-N glycolonitrile Natural products N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- ZTVZLYBCZNMWCF-UHFFFAOYSA-N homocystine Chemical compound [O-]C(=O)C([NH3+])CCSSCCC([NH3+])C([O-])=O ZTVZLYBCZNMWCF-UHFFFAOYSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229960002358 iodine Drugs 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011781 sodium selenite Substances 0.000 description 2
- 229960001471 sodium selenite Drugs 0.000 description 2
- 235000015921 sodium selenite Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000001562 sternum Anatomy 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 208000016794 vitamin K deficiency hemorrhagic disease Diseases 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- JZCAHRHZFBBFRZ-WCCKRBBISA-N (2s)-2-amino-4-methylsulfanylbutanoic acid;copper Chemical compound [Cu].CSCC[C@H](N)C(O)=O JZCAHRHZFBBFRZ-WCCKRBBISA-N 0.000 description 1
- KBPZVLXARDTGGD-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;iron Chemical compound [Fe].OC(=O)C(O)C(O)C(O)=O KBPZVLXARDTGGD-UHFFFAOYSA-N 0.000 description 1
- LRYZPFWEZHSTHD-HEFFAWAOSA-O 2-[[(e,2s,3r)-2-formamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium Chemical class CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](NC=O)COP(O)(=O)OCC[N+](C)(C)C LRYZPFWEZHSTHD-HEFFAWAOSA-O 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N 2-amino-4-methylselanyl-butanoic acid Chemical compound C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- ONFOSYPQQXJWGS-UHFFFAOYSA-N 2-hydroxy-4-(methylthio)butanoic acid Chemical compound CSCCC(O)C(O)=O ONFOSYPQQXJWGS-UHFFFAOYSA-N 0.000 description 1
- 108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 description 1
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 102000007132 Carboxyl and Carbamoyl Transferases Human genes 0.000 description 1
- 108010072957 Carboxyl and Carbamoyl Transferases Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000004481 Choline Deficiency Diseases 0.000 description 1
- 206010008723 Chondrodystrophy Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000006413 Digital Dermatitis Diseases 0.000 description 1
- 108090001081 Dipeptidases Proteins 0.000 description 1
- 102000004860 Dipeptidases Human genes 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 235000008418 Hedeoma Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010067997 Iodine deficiency Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000784728 Lycaena virgaureae Species 0.000 description 1
- 208000008167 Magnesium Deficiency Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000113306 Monascus purpureus Species 0.000 description 1
- 235000002322 Monascus purpureus Nutrition 0.000 description 1
- 241000031003 Monascus ruber Species 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- 241000238367 Mya arenaria Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 208000004286 Osteochondrodysplasias Diseases 0.000 description 1
- 206010031240 Osteodystrophy Diseases 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000005775 Parakeratosis Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 108010053763 Pyruvate Carboxylase Proteins 0.000 description 1
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 1
- 235000001498 Salvia hispanica Nutrition 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000000491 Tendinopathy Diseases 0.000 description 1
- 208000023835 Tendon disease Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 1
- 206010047631 Vitamin E deficiency Diseases 0.000 description 1
- 108091005605 Vitamin K-dependent proteins Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- OBODKGDXEIUEIH-DAWLFQHYSA-N all-trans-3-hydroxyretinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CC(O)CC1(C)C OBODKGDXEIUEIH-DAWLFQHYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000743 anti-peroxide Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000012215 calcium aluminium silicate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 208000014884 cartilage development disease Diseases 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000014167 chia Nutrition 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 208000021752 choline deficiency disease Diseases 0.000 description 1
- 210000001136 chorion Anatomy 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960004643 cupric oxide Drugs 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000023867 digital dermatitis in cattle Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 201000011200 hepatorenal syndrome Diseases 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000037111 immune power Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 235000006479 iodine deficiency Nutrition 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000004764 magnesium deficiency Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960004011 methenamine Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- XXKNHBAFFJINCK-RVEJDSBJSA-N monascin Chemical compound C([C@@H]1[C@H](C(O[C@@]1(C)C1=O)=O)C(=O)CCCCC)C2=C1COC(\C=C\C)=C2 XXKNHBAFFJINCK-RVEJDSBJSA-N 0.000 description 1
- GFSMXLMQRWMHON-UHFFFAOYSA-N monascin Natural products CCCCCC(=O)C1C2C=C3C=C(OC=C3C(=O)C2(C)OC1=O)C=CC GFSMXLMQRWMHON-UHFFFAOYSA-N 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- GIKQHOXMDCDAPT-UHFFFAOYSA-N monascusone B Natural products CC=CC1=CC2=C(CO1)C(=O)C3(C)OC(=O)C(C3C2)C(=O)C GIKQHOXMDCDAPT-UHFFFAOYSA-N 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108010017314 prolyl dipeptidase Proteins 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 150000003716 vitamin K3 derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 208000024877 white muscle disease Diseases 0.000 description 1
- 229940110280 zinc methionine Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- CNMFGFBWPBBGKX-SCGRZTRASA-L zinc;(2s)-2-amino-4-methylsulfanylbutanoate Chemical compound [Zn+2].CSCC[C@H](N)C([O-])=O.CSCC[C@H](N)C([O-])=O CNMFGFBWPBBGKX-SCGRZTRASA-L 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Fodder In General (AREA)
Abstract
The invention discloses an n-3 fatty acid enriched laying hen feed and a production method thereof, and belongs to the technical field of feed. Optimal proportion of the laying hen feed is obtained by repeated scientific test, basic nutrition requirements of the laying period of laying hens are fully considered, the effects of the components are complementary and coordinated, and n-3 fatty acid enriched linseed cake pulp and chia seeds are strengthened; by using the feed for raising the laying hens, the body immunity of the laying hens can be improved, the utilization rate of the feed is improved, digestion and absorption of nutrient substances are promoted, and the laying performance of the laying hens is effectively improved; and particularly, the n-3 fatty acid content of eggs can be improved, the cholesterol content of the eggs is reduced, and the quality of the eggs is promoted. In the eggs produced by the laying hens raised by using the feed, the n-3 fatty acid content of average 100 grams of yolk can reach 2,100 to 4,902.1 milligrams and is 8 to 15 times that of common eggs.
Description
Technical field
The present invention relates to a kind of egg feedstuff and production method thereof, relate in particular to a kind of egg feedstuff and production method thereof that mixes with the linseed grouts that are rich in n-3 aliphatic acid and other various ingredients, belong to field of feed.
Background technology
Egg contains a large amount of vitamin and mineral matter and the protein of high biological value is arranged, and is one of human best source of nutrition.The protein quality of egg is best, is only second to breast milk.The amino acid ratio of egg protein is well suited for Human Physiology to be needed, is prone to body absorbs, and utilization rate is up to more than 98%, and nutritive value is very high.According to one's analysis, every hectogram egg contains protein 14.7 grams, is mainly ovalbumin and ovoglobulin, wherein contains 8 seed amino acids of needed by human, and very approximate with the composition of human body protein.Fatty 11~15 grams of every hectogram egg mainly concentrate in the yolk, are also very easily absorbed by human consumption; Contain abundant lecithin, steroid, lecithin and calcium, phosphorus, iron, vitamin A, vitamin D and B family vitamin in the yolk, these compositions are favourable to nervous system and body development, the ability brain tonic and intelligence development; Improve memory; And the promotion liver cell regeneration, therefore, egg is again a brain-care foods preferably.Contain higher cholesterol and triglycerides in the egg yolk, cholesterol can be up to 1705mg in every hectogram yolk, and excessive absorption cholesterol can cause the generation of atherosclerotic and angiocardiopathy, influences health.
Polyunsaturated fatty acid (PUFA) is one type and contains two keys more than 2 or 3, and carbon number is 16 to 22 direct-connected aliphatic acid.PUFA mainly comprises n-3, n-6, n-9 series fatty acid, but what have that important biomolecule learns meaning is n-3, n-6 series.Discover that n-3 content and n-6/n-3 ratio are closely related in incidence and the meals of human cardiovascular and cerebrovascular disease, when ratio is inappropriate, can improve the incidence of cardiovascular and cerebrovascular disease.The n-6/n-3 ratio is generally 20~30 in China resident meals: 1 and 5: 1 of World Health Organization suggestion differ greatly.So n-3 unsaturated fatty acid content in the raising meals, the n-6/n-3 ratio is significant in the reduction meals.Egg is to make unsettled unrighted acid obtain stable good medium of preserving, and absorbing capacity n-3 unrighted acid through edible egg is a kind of effective way.According to bibliographical information, the n-3 unsaturated fatty acid content is lower in the common egg, and content is about about 200~300mg in general every 100mg yolk.
Summary of the invention
The object of the invention provides a kind of egg feedstuff feed and production method thereof of enrichment n-3 aliphatic acid.
Contain among the every 1000g of egg feedstuff of said enrichment n-3 aliphatic acid:
Linseed grouts 20~100g; Strange inferior seed 5~50g; Hawthorn 10~30g; Zeolite powder 10~50g; White carbon 20~100g; Fish meal 40~150g; Dregs of beans 40~100g; Wheat bran 40~80g; Silkworm chrysalis 40~80g; Carrot 5~20g; Oyster shell whiting 5g~15g; Bone meal 5~15g; Soya-bean oil 5~15g; Garlic powder 1~5g; Salt 1~3g; Zytase 0.1~1g; Phytase 0.1~0.5g; Lysozyme 0.1~0.5g; 3-Hydroxyretinol 00~1500IU; Vitamin D 50~500ICU; Vitamin E 2~10mg; Vitamin K 0.02~0.5mg; Cobastab
120.001~0.05mg, biotin 0.01~0.1mg, choline 0.1~0.5g, folic acid 0.05~0.5mg, nicotinic acid 1~10mg, pantothenic acid 0.5~10mg, Cobastab
60.5~10mg, riboflavin 0.5~10mg, thiamine 0.1~1mg, calcium 5~15g, phosphorus 1~3g, magnesium 20~100mg, copper 1~10mg, manganese 5~20mg, zinc 5~20mg, iron 10~25mg, selenium 0.01~0.1mg, iodine 0.01mg~0.1mg, methionine 0.5~2g, lysine 0.5~3g, tryptophan 0.5~3g, surplus is a corn.
Contain among the preferred every 1000g of the egg feedstuff of said enrichment n-3 aliphatic acid:
Linseed grouts 30~80g; Strange inferior seed 5~20g; Hawthorn 10~20g; Zeolite powder 10~30g; White carbon 20~60g; Fish meal 40~120g; Dregs of beans 40~80g; Wheat bran 40~80g; Silkworm chrysalis 40~80g; Carrot 5~20g; Oyster shell whiting 5g~15g; Bone meal 5~15g; Soya-bean oil 5~15g; Garlic powder 1~3g; Salt 1~3g; Zytase 0.1~1g; Phytase 0.1~0.5g; Lysozyme 0.1~0.5g; Vitamin A 300~800IU; Vitamin D 50~100ICU; Vitamin E 2~5mg; Vitamin K 0.02~0.1mg; Cobastab
120.001~0.01mg, biotin 0.01~0.05mg, choline 0.1~0.3g, folic acid 0.05~0.1mg, nicotinic acid 1~5mg, pantothenic acid 0.5~3mg, Cobastab
60.5~2mg, riboflavin 0.5~2mg, thiamine 0.1~0.5mg, calcium 5~10g, phosphorus 1~2g, magnesium 20~80mg, copper 1~5mg, manganese 5~15mg, zinc 5~15mg, iron 10~20mg, selenium 0.01~0.05mg, iodine 0.01mg~0.05mg, methionine 0.5~1g, lysine 0.5~1g, tryptophan 0.5~1g, surplus is a corn.
Each vitamin, mineral matter and amino acid consumption do not comprise the corresponding composition that is derived from linseed grouts, strange inferior seed, hawthorn, zeolite powder, white carbon, fish meal, dregs of beans, wheat bran, silkworm chrysalis, carrot, oyster shell whiting, bone meal, soya-bean oil, garlic powder, salt, zytase, phytase, lysozyme, the corn in the said prescription; Those skilled in the art can select each vitamin, mineral matter and origin of amino acid according to prior art, and the present invention does not do concrete qualification; For example said manganese, zinc, iron, copper, iodine, selenium can be respectively by manganese sulfate MnSO
45H
2O, zinc sulfate ZnSO
47H
2O, ferrous sulfate FeSO
47H
2O, copper sulphate CuSO
45H
2O, KI KI, sodium selenite Na
2SeO
3Provide.
Said egg feedstuff production method may further comprise the steps:
A. prepare B B-complex: take by weighing each vitamin (vitamin A, vitamin D, vitamin E, vitamin K, Cobastab by prescription
12, biotin, choline, folic acid, nicotinic acid, pantothenic acid, Cobastab
6, riboflavin, thiamine), mix with an amount of zeolite powder or white carbon (as 10~20 times);
Preparation composite mineral matter: take by weighing each mineral matter (calcium, phosphorus, magnesium, copper, manganese, zinc, iron, selenium, iodine) by prescription, mix with an amount of zeolite powder or white carbon (as 10~20 times);
Preparation compound amino acid: take by weighing each amino acid (methionine, lysine, tryptophan) by prescription, mix with an amount of zeolite powder or white carbon (as 10~20 times);
Preparation complex enzyme: take by weighing each enzyme (zytase, phytase, lysozyme) by prescription, mix with an amount of zeolite powder or white carbon or corn flour (as 10~20 times);
With the B B-complex that makes, composite mineral matter, compound amino acid, complex enzyme, mix with zeolite powder, white carbon, process premix;
B. take by weighing other raw material by prescription, mix, process egg feedstuff with above-mentioned premix.
Because of each vitamin, mineral matter, amino acid, enzyme dosage in the prescription less relatively, the premix of adopting said method to make in advance, can be easily with prescription in other raw material mixed preparing; This premix also has the following advantages:
1) this premix has better flowability, improves the mixture homogeneity of composition in feed, and is easy to operation, and avoided the loss of activity or the reduction that cause in transportation, the storage process effectively;
2) this premix can also improve feed intake and the efficiency of feed utilization of laying hen, makes laying hen have certain hobby property and dependence to this premix;
3) this premix both can be used separately, also can make things convenient for easily to mix with any standard feed/basal feed, and this premix can be applied in plant extensive, simple and effectively.
Flax: also claim flax, Linum usitatissimum L. is one of the world ten big oil crops.Linseed contains 34% grease, and flax machine presses the dregs of rice and contains the crude fat about 5%, and what the linseed fat content was the highest is unrighted acid, wherein the leukotrienes large percentage.Leukotrienes is the precursor of the necessary aliphatic acid n-3 high unsaturated fatty acid of animal, and after animal searched for food, meat, egg, milk also can contain a large amount of n-3 high unsaturated fatty acids.Linseed is rich in albumen, mainly is made up of albumin and globulin, is quality plant albumen.The byproduct linseed cake or the flaxseed meal of linseed oil expression, its gross protein value is 32%~36%, lysine and methionine content are respectively 1.10% and 0.47%.Because of lysine content is not enough, mixes and feed so the linseed grouts should contain the high protein feeds of lysine with other.The linseed grouts have the stomach of promotion, enterocinesia and improvement by the function of hair.Linseed cake contains the cyanogen glycosides, after the cyanogen glycosides gets into body, can under the effect of lipolytic enzyme, hydrolysis produce hydrogen cyanide and cause the poisoning of livestock and poultry.When linseed cake is made feed, should carry out attenuation treatment.General commonly used method is: linseed cake is pulverized, is added 4~5 times of warm water, soaks that drop anhydrates after 8~12 hours, add proper amount of clear water again and boiled 1 hour, when boiling, constantly stir and open wide pot cover, add vinegar simultaneously, volatilize so that hydrogen cyanide is tried one's best.
Strange inferior (Chia): formal name used at school chia Salvia Hispanica L., pennyroyal originates from Mexico south and Guatemala.It is to be rich in the abundantest food of omega-3 aliphatic acid, and contains natural.Strange inferior seed is the safety food of U.S. FDA authentication, also is the bread adding ingredient that European Union's legislation is confirmed.Strange inferior seed nutritional labeling: Omega-3 aliphatic acid: strange inferior seed 17.6%, strange inferior oily 63.8%; Strange inferior seed is that to contain Omega-3 the abundantest, the unique natural food that need not process direct safe edible; Compare with fish oil, the Omega-3 content of fatty acid of strange inferior seed is higher, and does not have cholesterol, can not cause allergy, the marine pollutant of no nutrition accumulation; Compare with linseed, strange inferior seed does not contain any harmful composition, and self contains the nature polyphenoils, has protected the quality of Omega-3, and it is rotten to addle easily unlike linseed, produces noxious material and peculiar smell; Polyphenoils: oxidation resistance ORAC is 9800, except common anti-oxidant element (vitamin E, C and lecithin) in addition, strange inferior seed contains abundanter natural, is the essential of anti-ageing diseases prevention anti-cancer; Strange inferior seed is the edible plant of unique safety in the Omega-3 source of having found at present, and does not contain cholesterol fully.
Red colouring agent for food, also used as a Chinese medicine: Fermentum Rubrum; Be to be raw material with the long-grained nonglutinous rice; The monascus ruber (monascuspurpureus) that adopts modern biotechnology to isolate high-quality forms through the liquid deep layer fermenting exquisiteness, is a kind of pure natural, safe, the food additives that are of value to health.Property is sweet, warm, nontoxic.Return liver; Spleen; Stomach; Large intestine channel.Separable behind the red koji fermentation to Co-Q10; Co-Q10 has another name called the decene quinone, is the activator of cellular metabolism and cellular respiration, can improve the mitochondrial respiratory function; The accelerating oxidation phosphorylation reaction; Itself is again the natural oxidant that cell self produces, and can suppress mitochondrial peroxidating, and the function of protection biofilm structure integrality is arranged.Immunity there is non-specific humidification, can improves cytophagous phagocytic rate, increase production of antibodies, improve the T cell function.The contained monascin K of red colouring agent for food, also used as a Chinese medicine can stop the generation cholesterol.
Zeolite powder: zeolite powder is natural levigate the forming of zeolite rock, and color is a white.Zeolite is the aluminium silicate mineral of a kind of shape structure of slag formation.It contains cultivated animals and grows required whole macroelements with most of micro-.These elements all exist with ionic condition, can be utilized by cultivated animals.Zeolite also has unique adsorptivity, catalytic, ion exchangeable in addition, and the selectivity of ion, acid resistance, heat endurance, many compositions property reach very high biologically active and mithridatism etc.Zeolite powder can improve the flowability and the homogeneity of premix composition.
White carbon: white carbon is the general name of white powder X-ray amorphous silicic acid and silicate product, mainly is meant precipitated silica, aerosil, superfine silicon dioxide gel and aeroge, also comprises Powdered synthetic aluminium silicate and calcium silicates etc.White carbon is a porous material, can be dissolved in caustic alkali and hydrofluoric acid, water insoluble, solvent and acid (except for hydrofluoric acid).As anti-caking agent; White carbon can be used in some products and improves free mobility, like plastic products, manufacturing rubber sulphur and the agglomeration resistance mixture of lawn groom, fungicide, emery wheel grinding agent, laundry bleach, phenolic aldehyde injection moulding methenamine, phenol and urea.Can be used on many industries such as fire-fighting agent, feed, cosmetics, delustering agent, pigment, paint in addition.White carbon can improve the flowability and the homogeneity of premix composition.
Vitamin A: the structural integrity that in the chicken body, can keep respiratory tract, alimentary canal, genital tract epithelial cell or mucous membrane is with sound; Promote growing of chick; Strengthen adaptive faculty and the resistance of chicken to environment; Improve egg production and the hatching of breeding eggs rate of chicken.When chicken is deficient in vitamin A, be prone to cause epithelial tissue drying and keratinization, make secretion hypodynamia, scheroma takes place in the sex change of cornea epithelium, causes blind when serious; Chick growth is slow, the fluffy and disorderly tarnish of feather, indigestion; Become chicken egg productivity to reduce, fertility rate of hatching egg is low, and incubation rate also descends.General mixed feed contains carrotene and luteole for every kilogram; Be about as much as retinol1 000 international unit; Can not satisfy the needs of chicken far away, so for the cage bird of not feeding green forage, vitamin A mainly relies on the multivitamin additive to provide.
Vitamin D: in the bone of poultry, hard beak, toe pawl and eggshell forming process, have the metabolism of regulating calcium, phosphorus, can promote of the absorption of chicken body, the heavy calcium skeletonization in the bone tissue is also had direct facilitation to calcium.When being deficient in vitamin D in the feed, can make calcium, phosphorus metabolism generation obstacle in the body, make chick that rickets take place.When being deficient in vitamin D in the bird inlay feed, symptom just occurs after 2-3 month, the initial stage is produced shell egg or soft-preserved egg, and egg production descends subsequently, and incubation rate reduces, beak, toe pawl, breastbone deliquescing, arthrocele.Rib and breastbone joint cave in, and all ribs are inwardly curved along thorax, and sick chicken is extremely weak.
Vitamin E: biological function mainly is an antioxidation, and protection unrighted acid (PUFA) especially linoleic acid is avoided autoxidation.Vitamin E not only can be removed free radical, can also remove the potential source that forms lipoperoxide.The lipid peroxidation reaction level improved when vitamin E and selenium had collaborative antioxidation TD, and membrane structure wrecks, and the activity of serum glutamic oxalacetic transaminase (GOT), lactic dehydrogenase enzymes such as (LDH) increases.Vitamin E can reduce the content of glucocorticoid in the blood, suppresses the generation of prostaglandin.Vitamin E has important effect to a lot of hormones synthetic, like tethelin, cortex hormone of aadrenaline.When the synthetic reduction of anterior pituitary gonadotropin, the reproduction function reduces.The generation of vitamin e deficiency is relevant with feed to a great extent.
Vitamin K: being the derivative of menadione, having another name called coagulation vitamin or antihemorrhagic vitamin, is to form necessary kind of vitamin of factor in the animal body.Vitamin K mainly act as the synthetic of factor and thrombokinase in the catalysis liver, thrombokinase impels factor to change fibrin ferment into, keeps the normal coagulation function of blood.Chick vitamin K deficiency causes subcutaneous hemorrhage to present purple plague purpura; Plant the not enough incubation rate reduction of vitamin K in the chicken feed.Except that hemoglutination, it is reported that vitamin K dependent protein matter and peptide are participated in calcium metabolism.When intestines problem or animal were taken broad-spectrum antibiotic and antibacterial medicine preparation for a long time, the enteric microorganism vigor descended, and can cause vitamin K deficiency.
Cobastab
12: be Cobalamin again, cyanocobalamin, cobalamin.Cobastab
12Be red, pink crystallization, more stable in weak acid, not alkaline-resisting, sunlight, oxidant or reducing agent.Cobastab
12Participating in the metabolism of a carbon-based group in the body, is the coenzyme that transmits methyl, and it connects each other with the effect of folic acid, influence the formation of the required active methyl of the interior biosynthesis of body and the metabolism of other carbon-based groups.Wherein the most important thing is to participate in the biosynthesis of nucleic acid and protein, promote erythrocytic growth and maturation.Work as Cobastab
12During shortage, can cause the animal pernicious anaemia, in addition, obstacle also takes place in other tissue metabolisms.Cobastab
12Also promote the generation of choline.The muscular stomach mucosal inflammation often takes place in poultry, and chick growth is bad, and the hatching of breeding eggs rate descends, and rate of embryonic death raises, and feather growth is bad etc.Cobastab
12The BA of folic acid can be activated, Cobastab can be used when chicken lacks folic acid
12Supplemental treatment; Share with vitamin C, the effect that promotes chicken to grow is remarkable.In addition, pantothenic acid strengthens Cobastab
12Effect.
Biotin: have another name called biotin; It is the coenzyme of many carboxylases and carboxyl transferase system in the animal body; Participating in metabolism such as fat, carbohydrate, protein, amino acid, nucleic acid, is animal skin, indispensable by keeping of hair, pad, hoof, reproductive system and nervous system normal development and health.When bird lacks, beak and digital dermatitis, the claw distortion, the hatching of breeding eggs rate descends, and fatty liver renal syndrome (FLKS) takes place, poor growth, survival rate reduces.Preliminary data proves that biotin can also improve the facilitation of copper to growth, reduces the thickness of backfat, improves the ketoboidies quality.The research of nearly more than ten years is bright, because content is big in the feed, utilization rate is low, and depending merely on natural feed provides biotin can not satisfy poultry, fowl needs, must add industrial biotin; The biotin that adds higher amount can improve the resistance against diseases of livestock and poultry, prevents the hepatorenal syndrome (FLKS) of chicken fat, reduces the chicken sudden death, and it is sick to reduce chicken leg; Prevent that the productivity that livestock and poultry stress cause from descending.
Choline: the oxyhydroxide of beta-hydroxy ethylamine is a kind of highly basic.It is distributed widely in the organism with the form of free choline, acetylcholine and composite phospholipid; Its physiological function: 1. choline is as the composition of lecithin, sphingomyelins; Play an important role with keeping on the cell function in the formation eucaryotic cell structure; Participation fat is thanked, and can prevent fatty liver, the shin bone tubbiness disease of liver, nephrorrhagia and chicken and turkey.2. participate in the conduction of nerve impulse with the acetylcholine form.3. choline is a kind of methyl donor.Research shows, exists or contains under the mineral sulfates condition at homocystine, adds choline and can save methionine.The animal choline is not enough, causes fat metabolic disturbance, fatty liver occurs, liver, kidney, eyeball and other organ hemorrhages, nervous disorder.Poultry bone, joint deformity, enlargement, shin stomach tubbiness, the speed of growth descends.It is reported that some chicken that produces brown shell egg produces the egg that has a fish like smell when feeding rape cake relevant with the choline deficiency.
Folic acid: by separating in the plant, so be referred to as folic acid, it is to participate in metabolism in animal body with the form of tetrahydrofolic acid at first.Through the transmission of a carbon-based group being participated in the synthetic and amino acid whose metabolism of fast cry of certain animals, pyrimidine, thereby influence the metabolism of the synthetic and protein of nucleic acid,, and can promote the generation of immunoglobulin (Ig) the facilitation that is formed with of normal plasma cell.Animal lacks folic acid and often causes anaemia, red blood cell minimizing, and growth stops, and fowl also shows as the vertebra paralysis, the feather decolouring, and fertility reduction and rate of embryonic death are high, are apparent that the short and thick and mouth interleaved shape of embryo's shin bone especially.Usually need Supplement of folic acid to prevent deficiency disease to fowl, promote production effect, improve immunity.
Nicotinic acid: nicotinic acid and niacinamide are generically and collectively referred to as nicotinic acid or nicotinic acid, are one of more stable vitamin, are difficult for being destroyed by heat, oxygen, light, alkali, acid.Nicotinic acid and niacinamide have same physiological function.Nicotinic acid can be converted into niacinamide in animal body, and niacinamide is the part of DPN, DPN I.And DPN, DPN I are the coenzyme of many dehydrogenases, play a part to transmit hydrogen in vivo in the redox reaction, it and glycolysis; Fat metabolism; The pyruvic acid metabolism, the generation of energy-rich phosphate bond has substantial connection, and in keeping skin and digestive organs normal function, plays an important role.The PP animal that is deficient in vitamin produces cutaneous lesions, bark favus occurs, disease of digestive tract, and growth retardation, mucous membrane inflammation and ulcer, feather growth is bad, and egg production and incubation rate descend, and cause the short and thick disease of poultry shin bone.
Pantothenic acid: have another name called pantothenic acid, the chicken adermin is a kind of dipeptidase derivant, is yellow thickness oily, and xeothermic reaching in acid, aqueous slkali is prone to be destroyed.Pantothenic acid is the constituent of coacetylase, the metabolism of coacetylase involved in sugar, fat and protein.Pantothenic acid plays crucial effect the synthetic of fat with in decomposing, and with the color and luster of the normal function of skin and mucous membrane, fur with to the resistance of disease very big relation is arranged.Animal lacks the pathology that pantothenic acid mainly causes skin and mucous membrane, and it is coarse or feather is rare to show as epidermis, hair or shed feathers, and growth retardation, reproductive function generation obstacle.Disease-resistant and anti-copingability descends.Chick then shows as undergrowth, and feather is messy, and dermatitis, eye secreting mucus increase, and beak angle and toe form crust.The hatching of breeding eggs rate descends.Pantothenic acid still is the essential nutrients of many microorganisms, and lacking to influence microbial growth.
Cobastab
6: be the general name of pyridoxol, Vitamin B6, pyridoxamine, these three kinds of materials have identical biological action in animal body.Cobastab
6It is the important component part of many amino acid decarboxylases, transaminase etc.Contain vitamin people B
6Enzyme participate in nearly all amino acid whose synthetic and catabolism, also very important to the metabolism of fat, sugar, inorganic salts in addition.B is deficient in vitamin
6The time, young animal poor growth or stop.The chicken B that is deficient in vitamin
6The time, excitability is strong, and refreshing play symptom is arranged, and leg is weak, dermatitis, depilation, hair is assisted hemorrhage, and the death rate raises, and laying rate, hatching of breeding eggs rate descend.Chick is prone to produce deficiency disease.Improve the daily ration Cobastab
6But addition enhance immune power and anti-stress ability.Adult ruminant generally need not to replenish.
Riboflavin: both Cobastabs
2, riboflavin is the isoalloxazine derivative, orange colour is prone to destroyed by alkali, light and metallic element.Riboflavin is the important component part of many oxidoreducing enzyme, participates in energy and protein metabolism.Animal lacks the nuclear Huang and causes the body metabolic disorder.Its symptom: gently then show as growth retardation, productivity descends; The classical symptom of chick is the heel arthroncus, and the toe inflexion becomes the fist shape, and acute deficiency disease can make shank complete paralysis, paralysis; When planting the chicken shortage, the hatching of breeding eggs rate is low, and survivability of chicks is low.Animal need be relevant with environment temperature with the daily ration composition to riboflavin, and diet nutrient concentration is high, and then the riboflavin requirement increases, and environment temperature is low should give more riboflavin, and the requirement of stud bird animal is higher.
Thiamine: i.e. Cobastab
1Have another name called antineuritic vitamin; Anti beriberi vitamin is the coenzyme composition in the alpha-ketoacid dehydrogenase system, participates in the metabolism of carbohydrate; Normal function to keeping nerve fiber and cardiac muscle plays an important role, and keeps normal creepage of gastrointestinal functions and the gastric secretion of stomach and disappears than the fatty absorption in road and the normal function of fermentation.Cobastab
1Lack, then disturbance of carbohydrate metabolism, neural, myocardial function is unusual, shakes indigestion, growth retardation etc. under the appetite.Cobastab
1Requirement and feed in soluble-carbohydrate content relevant, soluble-carbohydrate content is higher, Cobastab
1Requirement increases.
Calcium: calcium is most of in chicken class body to be combined into calcium phosphate with phosphorus, generally accounts for the 65-70% of content of mineral substances in the body, is the main component of formation bone and chorion, and in the egg-laying season, nestling especially should be added enough calcium and phosphorus growth period.Calcium is also participated in the solidifying etc. of activity and blood of cell.Calcium, phosphorus lack or are out of proportion, all can cause suffering from rickets, rickets, also can make osteoporosis, produce the soft shell ovum, even stop production.Calcium deficiency can cause that blood calcium reduces, and chick and the growth of young chicken are slow, depauperation, osteoporosis, keel are crooked, performance " rickets "; Similar with vitamin D deficiency, laying hen egg production then occurs and descends, and produces soft-shelled egg; Shell egg or do not have the shell egg when serious, even paralysed disease can occur.Certainly the shortage of calcium will inevitably cause the absorption of phosphorus, utilization to reduce the calcium phosphorus ration detuning phenomena.Bone meal, shrimp med, fish meal, blood meal, calcium tablet, oyster shell whiting, lime stone, calcium monohydrogen phosphate and eggshell are the main sources of calcium, and it is the bone that constitutes chicken, the main component of eggshell, and relevant with nervous function, muscle activity, blood clotting.The shell calcic is many, and chicken is prone to absorb, but keeps the limited in one's ability of calcium in the chicken body, therefore preferably feeds a part of fragment shell to laying hen, chicken is slowly digested, to satisfy the needs that chicken is laid eggs.The chick calcium deficiency is suffered from osteomalacia, becomes chicken calcium deficiency egg production to reduce, and eggshell thinning even the no shell egg of product or incubation rate descend.Supply the too much unfavorable chick growth of calcium, influence the absorption of magnesium, manganese, zinc.Chalk shape deposition is arranged on the eggshell, and the egg two ends are coarse possibly to be that hen feeds the too much result of calcium.Bone meal and calcium phosphate and good phosphorus, calcium feed.
Phosphorus: be the main component that forms bone, with energetic supersession and to keep in the body normal osmotic pressure relevant with acid-base balance.Chicken poor growth when lacking phosphorus, bone is frangible, arthrosclerosis when serious.Phosphorous more in cereal and the bran, but the utilization rate of chicken is low, therefore in daily ration, must replenish a part of Phos, will note supply when in daily ration, lacking fish meal especially.
Calcium phosphorus lacks and calcium phosphorus ration imbalance (Dietary Deficiency of Calcium in the feed; Phosphrorus and Imbalance of the Calcium:Phosphorus Ratio) calcium and phosphorus lack in the poultry feed, and the calcium phosphorus ration imbalance be osteodystrophy main diseases because of.The not only formation of influence growth poultry bone, the formation of female bird eggshell of growing up, and influence the normal functions such as blood clotting, acid-base balance, N&M of poultry, the economic loss that causes is huge.
Magnesium: magnesium is the key element in glandular tissue and the musculature, is the catalyst of various enzymes, participates in the substance in vivo metabolic process.Can in feed, add magnesium sulfate during magnesium deficiency, but unsuitable excessive.
Salt: sodium chloride: sodium chloride is the constituent of salt, is prevalent in blood, body fluid, soft tissue and the ovum of wild chicken class, and salt can be regulated the taste of feed; Promote gastric secretion, whet the appetite, promote the utilization of nitrogen in the food; Keep acid, soda balance in their bodies; Keep the balance of osmotic pressure between cell and blood, make tissue can keep certain moisture, can also impel digesting and assimilating of protein and fat.Salt is not enough, and chick growth is slow, is prone to pernicious habits such as pecking anus, poor appetite can occur, indigestion, and hypoevolutism, symptom such as lose weight.
Copper: participate in the synthetic and activation of hemoglobin and many oxidoreducing enzyme, the utilization of copper and iron is relevant, and during hematopoiesis, erythrocytic formation must just can be carried out in the presence of CER, also causes anaemia so lack copper.Copper, iron, cobalt are called as the hematopoiesis element.Scarce copper also causes the collagenous fibres biosynthesis block in the sclerotin, and skeleton development is influenced, osteoporosis, and long bone is frangible.In addition; Copper also with the normal development of animal blood vessels and normal function, relevant by hair growth and quality, central nervous system, reproductive capability, the deficiency disease of livestock and poultry copper shows as: anaemia (decline of serum copper content), the stagnation of growing, neurological disorders, coordinate movement imbalance, tetraparesis are unable.Copper irritates growth and similar antibiotic pharmacological action in addition.Mostly the fill-in of copper is copper sulphate, cupric oxide, copper carbonate etc.
Manganese: be arginase, prolinase, pyruvate carboxylase, RNA polymerase, contain the constituent of manganese superoxide dismutase (Mn-SOD) etc.; And can activate many enzymes; Comprise some kinases, hydrolase, decarboxylase and transferase etc.; Through these enzymes; Manganese is participated in the metabolism of protein, DNA and ribonucleic acid, lipid, carbohydrate, and to the normal growth and the structure of the growth of animal, growth, breeding, bone, hematopoiesis, nerve etc. all has significant effects.Manganese deficiency mainly shows as growth retardation, skeleton deformity, reproduction disorder, new born animal ataxia and lipid, carbohydrate metabolism defective.Poultry is prone to take place manganese deficiency " slide tendon disease ", and the hatching of breeding eggs rate descends, chicken embryo chondrodystrophy.
Zinc: be the constituent of many metal enzymes and hormone (like insulin), known have the activity of 80 plurality of enzymes relevant with zinc.Zinc is participated in protein, carbon water compound and lipid metabolism through enzyme and hormone, participates in synthesizing of DNA and ribonucleic acid, also with the growth of hair; The health of skin, the healing of wound, reproductive capability; Skeleton development, the sense of taste and appetite etc. are relevant, and some discovers that zinc participates in the composition of vitamin A reductase in liver and the retina; The level of keeping the blood plasma vitamin A there is certain effect, also participates in keeping the normal immunity function of body.Animal lacks zinc and shows as appetite and descend, and decreased growth is given milk, egg drop reduction, and efficiency of feed utilization is low, and severe patient grows and stops, and is thick disorderly by hair, come off, parakeratosis of skin, and skin is cracked from dryness, and wound is difficult for healing, diarrhoea, vomiting even dead.
Iron: iron is to constitute hemoglobin, myoglobins, cytochromes and multiple oxidasic important component, as the carrier of oxygen, guarantees the normal conveying of oxygen in the soma; Participate in oxidation-reduction process complicated in the body.Modern study proves, its biochemical action of competence exertion when having enzyme iron content or iron 1/2 or more to exist in the tricarboxylic circulation, completion physiological function; Utilizing of iron deficiency or iron is bad, will cause transportation, the storage of oxygen, the transportation and the equivalent journey disorder of apologizing for having done sth. wrong of redox of carbon dioxide, and influence is grown even various diseases such as anaemia is taken place.As the molysite of the fill-in of iron water-soluble and diluted acid capable of using, like ferrous sulfate, frerrous chloride ironic citrate, tartaric acid iron and iron gluconate, amino acid iron etc., the utilization rate of these iron is all fine.
Selenium: be the constituent of glutathione peroxidase, this enzyme can decompose the cell endoperoxide, prevents that the oxidation of cell membrane fat from destroying reaction, and the protection biomembrane exempts from infringement.Selenium can be strengthened the antioxidation of vitamin E, and the two has synergy on this physiological function.In feed, add vitamin E and can alleviate scarce selenium symptom, or postpone the death time, but can not fundamentally eliminate the cause of disease.When lacking selenium, animal body inner cell antiperoxide toxicity ability reduces, and cell oedema, hemorrhage occurred by peroxide breakdown, exudative diathesis, and necrosis of liver cells, the atrophy of spleen fibroid, muscle is undesired, muscular degeneration of heart.Show as white muscle disease, physiological function is disorderly, growth retardation, and chick is that exudative diathesis is sick.The additive of selenium is generally sodium selenite.
Iodine: be thyroxinic important composition composition.Most of iodine is present in the thyroid gland in the animal body, and is plain in order to synthetic thyroid, regulates metabolism.Its effect comprises that promotion protein is synthetic, and activation 100 plurality of enzymes are regulated the conversion of energy, and tachyauxesis is grown, and keeps central nervous system structures, guarantees the normal state of mind, body shape and metabolism etc.The animal iodine deficiency can cause a series of biochemical disorders and physiological function unusual, mainly causes basal metabolic rate and vigor to descend.
Methionine: at present as the product of methionine additive mainly contain DL-methionine and DL-methionine hydroxy analog (Methionine Hydroxy Analoque, MHA) and calcium salt (MHACa).In addition, the methionine preparation also has methionine metal complex and the protectiveness methionine preparation that is used for ruminant.The development of methionine metallic element complex compound mainly is little to trace mineral supplement addition in feed; In feed, accurately add and mix the comparison difficulty; And inorganic elements toxicity is bigger; Some inorganic compound is prone to the moisture absorption caking, influences the stability of processing characteristics and other active components.And the amino acids metal element complex has overcome these deficiencies, and can improve additive effect and security.Commercial product goes on the market at present, and the methionine complex compound has zinc methionine, selenium methionine, copper methionine etc.
Lysine: the lysine that adds in the feed has two kinds, i.e. L-lysine and DL-lysine.Because of animal can only utilize L-lysine, so be mainly L-lysine product, DL-lysine product should be indicated L-lysine content guarantee value.As the feeding level lysine of commodity normally purity be the L lysine HCL 98.5% or more, be equivalent to contain lysine (active ingredient) more than 78.8%, for a white faint yellow particulate powder, peculiar smell is arranged slightly, soluble in water.L-lysine more than 90% is to be the product that fermenting raw materials is produced with molasses.
Tryptophan: tryptophan is the 3rd or the 4th limiting amino acid normally.See it is very important a kind of essential amino acid from the nutrition angle, in the daily ration that has generally added methionine and lysine, the tryptophan interpolation becomes more important.In addition, the metabolite 5-hydroxyl look ammonia of tryptophan animal body have anti-high density, wean etc. stress, promote the generation of gamma globulin, strengthen the effect of carcass premunition.
Enzyme preparation: enzyme preparation can help to replenish self not enough endogenous digestive ferment, improves the secretion and the activity of endogenous enzymes, promotes digesting and assimilating nutriment; Simultaneously can destroy plant cell wall, eliminate ANFs in the feed, improve feed nutritive value, the price of deed can be greatly enhanced; And enzyme preparation can influence the livestock and poultry alimentary tract microorganism species, raising immunocompetence, the generation of minimizing disease.Enzyme preparation commonly used mainly comprises protease, amylase, cellulase, lipase, 1,4 beta-glucanase, phytase, lysozyme and pectase etc.
Egg feedstuff of the present invention is that scientific experimentation draws best proportioning through repeated multiple times, has considered the basic nutrition demand of laying cycle of laying hens comprehensively, and each component and effect is done mutually, coordinated, and emphasis has been strengthened the many trophic factors that influence the laying hen egg laying performance; Especially, this egg feedstuff has been strengthened linseed grouts and the Qi Ya seed that is rich in n-3 aliphatic acid; Use this feed to carry out the laying hen nursing, can impel laying hen to reach good figure, can improve the immunity of organisms of laying hen, improve efficiency of feed utilization, promotion is digested and assimilated nutriment, effectively improves the egg laying performance of laying hen; Specifically, can improve n-3 content of fatty acid in the egg, reduce cholesterol level, promote egg quality.
Through the production practices multiple authentication, experiment showed, in the egg that laying hen produced that uses forage feed of the present invention that middle n-3 content of fatty acid can reach 2100~4200mg in average every 100g yolk, is 8~16 times of common egg content.
The specific embodiment
The following stated embodiment does further explanation to the present invention, but should not be construed as any restriction of the present invention.
Embodiment
With production egg feedstuff of the present invention is example, and every 1000g fills a prescription as follows:
Embodiment 1~6 egg feedstuff production method may further comprise the steps:
A. prepare B B-complex: take by weighing each vitamin (vitamin A, vitamin D, vitamin E, vitamin K, Cobastab by prescription
12, biotin, choline, folic acid, nicotinic acid, pantothenic acid, Cobastab
6, riboflavin, thiamine), mix with an amount of zeolite powder or white carbon (as 10~20 times);
Preparation composite mineral matter: take by weighing each mineral matter (calcium, phosphorus, magnesium, copper, manganese, zinc, iron, selenium, iodine) by prescription, mix with an amount of zeolite powder or white carbon (as 10~20 times);
Preparation compound amino acid: take by weighing each amino acid (methionine, lysine, tryptophan) by prescription, mix with an amount of zeolite powder or white carbon (as 10~20 times);
Preparation complex enzyme: take by weighing each enzyme (zytase, phytase, lysozyme) by prescription, mix with an amount of zeolite powder or white carbon or corn flour (as 10~20 times);
With the B B-complex that makes, composite mineral matter, compound amino acid, complex enzyme, mix with zeolite powder, white carbon, process premix;
B. take by weighing other raw material by prescription, mix, process egg feedstuff with above-mentioned premix.
Test one:
Select 50 of the healthy laying hens of 300 ages in days, be divided into test group and control group at random, test group is fed embodiment 6 feeds; Control group is fed conventional feed, and two groups of feeding and management conditions are identical, feed 35d continuously; The result shows: test group is compared with control group, and average day egg production improves 10.12%, and feedstuff-egg ratio reduces by 9.25%; Broken (damage, soft) egg rate descends 45.33%, and the n-3 content of fatty acid reaches 2256.9mg/100g in the yolk, has raise 8.4 times than control group; Cholesterol descends 14.61%, and yolk SOD (superoxide dismutase) content improves 9.64%, and yolk MDA (liver MDA) reduces by 23.73%; Yolk color has increased by 2.1~2.5 organizational levels (standard colorimetric fan), and egg is longer storage period.
Test two:
Select 100 of the healthy laying hens of 330 ages in days, be divided into test group and control group at random, test group is fed embodiment 3 feeds; Control group is fed conventional feed, and two groups of feeding and management conditions are identical, feed 50d continuously; The result shows: test group is compared with control group, and average day egg production improves 15.52%, and feedstuff-egg ratio reduces by 13.26%; Broken (damage, soft) egg rate descends 48.98%, and the n-3 content of fatty acid reaches 3603.6mg/100g in the yolk, has raise 12.6 times than control group; Cholesterol descends 17.47%, and yolk SOD (superoxide dismutase) content improves 10.24%, and yolk MDA (liver MDA) reduces by 29.16%; Yolk color has increased by 2.2~2.5 organizational levels (standard colorimetric fan), and egg is longer storage period.
Test three:
Select 100 of the healthy laying hens of 330 ages in days, be divided into test group and control group at random, test group is fed embodiment 1 feed; Control group is fed conventional feed, and two groups of feeding and management conditions are identical, feed 50d continuously; The result shows: test group is compared with control group, and average day egg production improves 18.51%, and feedstuff-egg ratio reduces by 15.45%; Broken (damage, soft) egg rate descends 50.18%, and the n-3 content of fatty acid reaches 4092.1mg/100g in the yolk, has raise 15.1 times than control group; Cholesterol descends 19.12%, and yolk SOD (superoxide dismutase) content improves 9.83%, and yolk MDA (liver MDA) reduces by 25.09%; Yolk color has increased by 2.2~2.5 organizational levels (standard colorimetric fan), and egg is longer storage period.
Claims (4)
1. the egg feedstuff of an enrichment n-3 aliphatic acid is characterized in that, contains among every 1000g:
Linseed grouts 20~100g; Strange inferior seed 5~50g; Hawthorn 10~30g; Zeolite powder 10~50g; White carbon 20~100g; Fish meal 40~150g; Dregs of beans 40~100g; Wheat bran 40~80g; Silkworm chrysalis 40~80g; Carrot 5~20g; Oyster shell whiting 5g~15g; Bone meal 5~15g; Soya-bean oil 5~15g; Garlic powder 1~5g; Salt 1~3g; Zytase 0.1~1g; Phytase 0.1~0.5g; Lysozyme 0.1~0.5g; Vitamin A 300~1500IU; Vitamin D 50~500ICU; Vitamin E 2~10mg; Vitamin K 0.02~0.5mg; Cobastab
120.001~0.05mg, biotin 0.01~0.1mg, choline 0.1~0.5g, folic acid 0.05~0.5mg, nicotinic acid 1~10mg, pantothenic acid 0.5~10mg, Cobastab
60.5~10mg, riboflavin 0.5~10mg, thiamine 0.1~1mg, calcium 5~15g, phosphorus 1~3g, magnesium 20~100mg, copper 1~10mg, manganese 5~20mg, zinc 5~20mg, iron 10~25mg, selenium 0.01~0.1mg, iodine 0.01mg~0.1mg, methionine 0.5~2g, lysine 0.5~3g, tryptophan 0.5~3g, surplus is a corn.
2. according to the egg feedstuff of the said enrichment n-3 of claim 1 aliphatic acid, it is characterized in that, contain among every 1000g:
Linseed grouts 30~80g; Strange inferior seed 5~20g; Hawthorn 10~20g; Zeolite powder 10~30g; White carbon 20~60g; Fish meal 40~120g; Dregs of beans 40~80g; Wheat bran 40~80g; Silkworm chrysalis 40~80g; Carrot 5~20g; Oyster shell whiting 5g~15g; Bone meal 5~15g; Soya-bean oil 5~15g; Garlic powder 1~3g; Salt 1~3g; Zytase 0.1~1g; Phytase 0.1~0.5g; Lysozyme 0.1~0.5g; Vitamin A 300~800IU; Vitamin D 50~100ICU; Vitamin E 2~5mg; Vitamin K 0.02~0.1mg; Cobastab
120.001~0.01mg, biotin 0.01~0.05mg, choline 0.1~0.3g, folic acid 0.05~0.1mg, nicotinic acid 1~5mg, pantothenic acid 0.5~3mg, Cobastab
60.5~2mg, riboflavin 0.5~2mg, thiamine 0.1~0.5mg, calcium 5~10g, phosphorus 1~2g, magnesium 20~80mg, copper 1~5mg, manganese 5~15mg, zinc 5~15mg, iron 10~20mg, selenium 0.01~0.05mg, iodine 0.01mg~0.05mg, methionine 0.5~1g, lysine 0.5~1g, tryptophan 0.5~1g, surplus is a corn.
3. the egg feedstuff production method of an enrichment n-3 aliphatic acid may further comprise the steps:
A. prepare B B-complex: take by weighing each vitamin by prescription, mix with an amount of zeolite powder or white carbon;
Preparation composite mineral matter: take by weighing each mineral matter by prescription, mix with an amount of zeolite powder or white carbon;
Preparation compound amino acid: take by weighing each amino acid by prescription, mix with an amount of zeolite powder or white carbon;
Preparation complex enzyme: take by weighing each enzyme by prescription, mix with an amount of zeolite powder or white carbon or corn flour;
With the B B-complex that makes, composite mineral matter, compound amino acid, complex enzyme, mix with zeolite powder, white carbon, process premix;
B. take by weighing other raw material by prescription, mix, process egg feedstuff with above-mentioned premix;
Said feed formula for laying hen is to contain among every 1000g:
Linseed grouts 20~100g; Strange inferior seed 5~50g; Hawthorn 10~30g; Zeolite powder 10~50g; White carbon 20~100g; Fish meal 40~150g; Dregs of beans 40~100g; Wheat bran 40~80g; Silkworm chrysalis 40~80g; Carrot 5~20g; Oyster shell whiting 5g~15g; Bone meal 5~15g; Soya-bean oil 5~15g; Garlic powder 1~5g; Salt 1~3g; Zytase 0.1~1g; Phytase 0.1~0.5g; Lysozyme 0.1~0.5g; Vitamin A 300~1500IU; Vitamin D 50~500ICU; Vitamin E 2~10mg; Vitamin K 0.02~0.5mg; Cobastab
120.001~0.05mg, biotin 0.01~0.1mg, choline 0.1~0.5g, folic acid 0.05~0.5mg, nicotinic acid 1~10mg, pantothenic acid 0.5~10mg, Cobastab
60.5~10mg, riboflavin 0.5~10mg, thiamine 0.1~1mg, calcium 5~15g, phosphorus 1~3g, magnesium 20~100mg, copper 1~10mg, manganese 5~20mg, zinc 5~20mg, iron 10~25mg, selenium 0.01~0.1mg, iodine 0.01mg~0.1mg, methionine 0.5~2g, lysine 0.5~3g, tryptophan 0.5~3g, surplus is a corn.
4. according to the egg feedstuff production method of the said enrichment n-3 of claim 3 aliphatic acid, it is characterized in that said feed formula for laying hen is to contain among every 1000g:
Linseed grouts 30~80g; Strange inferior seed 5~20g; Hawthorn 10~20g; Zeolite powder 10~30g; White carbon 20~60g; Fish meal 40~120g; Dregs of beans 40~80g; Wheat bran 40~80g; Silkworm chrysalis 40~80g; Carrot 5~20g; Oyster shell whiting 5g~15g; Bone meal 5~15g; Soya-bean oil 5~15g; Garlic powder 1~3g; Salt 1~3g; Zytase 0.1~1g; Phytase 0.1~0.5g; Lysozyme 0.1~0.5g; Vitamin A 300~800IU; Vitamin D 50~100ICU; Vitamin E 2~5mg; Vitamin K 0.02~0.1mg; Cobastab
120.001~0.01mg, biotin 0.01~0.05mg, choline 0.1~0.3g, folic acid 0.05~0.1mg, nicotinic acid 1~5mg, pantothenic acid 0.5~3mg, Cobastab
60.5~2mg, riboflavin 0.5~2mg, thiamine 0.1~0.5mg, calcium 5~10g, phosphorus 1~2g, magnesium 20~80mg, copper 1~5mg, manganese 5~15mg, zinc 5~15mg, iron 10~20mg, selenium 0.01~0.05mg, iodine 0.01mg~0.05mg, methionine 0.5~1g, lysine 0.5~1g, tryptophan 0.5~1g, surplus is a corn.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103145969A CN102318777B (en) | 2011-10-17 | 2011-10-17 | N-3 fatty acid enriched laying hen feed and production method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103145969A CN102318777B (en) | 2011-10-17 | 2011-10-17 | N-3 fatty acid enriched laying hen feed and production method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102318777A CN102318777A (en) | 2012-01-18 |
CN102318777B true CN102318777B (en) | 2012-11-14 |
Family
ID=45446721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011103145969A Expired - Fee Related CN102318777B (en) | 2011-10-17 | 2011-10-17 | N-3 fatty acid enriched laying hen feed and production method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102318777B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102940164A (en) * | 2012-12-10 | 2013-02-27 | 胡军霞 | Fish feed |
CN103082147A (en) * | 2013-01-30 | 2013-05-08 | 李学禹 | Laying hen feed |
CN103815202B (en) * | 2014-03-07 | 2015-06-10 | 河南科技学院 | Various nutrients for laying hens, and preparation method thereof |
CN104206794A (en) * | 2014-06-26 | 2014-12-17 | 湖北绿科乐华生物科技有限公司 | Biological feed for improving flesh quality of obsolete laying hen and producing method thereof |
CN104187022A (en) * | 2014-06-26 | 2014-12-10 | 湖北绿科乐华生物科技有限公司 | Biological formulated feed capable of reducing skatole content in pork and production method thereof |
CN104171490A (en) * | 2014-06-30 | 2014-12-03 | 黄海英 | Formula of feed for laying hens |
CN104489288A (en) * | 2014-11-20 | 2015-04-08 | 广西大学 | Laying hen feed for improving egg laying rate |
CN104489418A (en) * | 2015-01-17 | 2015-04-08 | 河北农业大学 | Layer feed additive rich in omega-3 polyunsaturated fatty acid |
CN104799057A (en) * | 2015-04-02 | 2015-07-29 | 广西大学 | Digestive chicken feed |
CN104686867A (en) * | 2015-04-02 | 2015-06-10 | 广西科技大学 | Chicken fodder for enhancing immunity and preparation method thereof |
CN105614046A (en) * | 2015-12-25 | 2016-06-01 | 武汉净宇微藻科技有限公司 | Microalga feed additive and feed |
CN106472854A (en) * | 2016-09-30 | 2017-03-08 | 安徽华澳生物技术有限公司 | A kind of egg feedstuff for different growth phases laying period |
CN107041466A (en) * | 2016-11-24 | 2017-08-15 | 江苏爱西施科技服务咨询股份有限公司 | A kind of dorking addition agent containing modified abundant amino acids from silkworm pupa and preparation method thereof |
CN106578602A (en) * | 2016-11-24 | 2017-04-26 | 江苏爱西施科技服务咨询股份有限公司 | Laying hen feed additive containing modified silkworm chrysalis amino acids and preparation method thereof |
CN106615930A (en) * | 2016-12-09 | 2017-05-10 | 曾琼 | Duck feed |
CN106858127A (en) * | 2016-12-27 | 2017-06-20 | 广东杨氏农业有限公司 | A kind of egg feedstuff of natural green |
CN108783058A (en) * | 2017-04-28 | 2018-11-13 | 王海涛 | A kind of poultry feed |
CN107467392A (en) * | 2017-07-25 | 2017-12-15 | 成都和谐生物科技有限公司 | Suitable for the chicken feed addictive of laying period |
CN107484912A (en) * | 2017-07-27 | 2017-12-19 | 湖北省农业科学院畜牧兽医研究所 | It is a kind of to produce the feed rich in the polyunsaturated fatty acid quail eggs of ω 3 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1247107C (en) * | 2003-11-28 | 2006-03-29 | 张明东 | Egg chicken nutrious feed |
CN101449751B (en) * | 2007-11-30 | 2011-08-10 | 河南商都生物技术股份有限公司 | Laying-hens feedstuff rich in polyunsaturated fatty acid |
CN101181018B (en) * | 2007-12-13 | 2011-05-11 | 济南和美华饲料有限公司 | Hen feedstuff for producing healthy egg |
CN101268808B (en) * | 2008-05-21 | 2011-09-28 | 吴家泉 | Egg feedstuff rich in omega-3 fatty acid and preparation method thereof |
-
2011
- 2011-10-17 CN CN2011103145969A patent/CN102318777B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102318777A (en) | 2012-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102318777B (en) | N-3 fatty acid enriched laying hen feed and production method thereof | |
CN102415504B (en) | Laying hen forage premix containing DHA enriched in algae protein powder | |
CN103564176B (en) | Pig feed and preparation method thereof | |
CN101502297B (en) | Feed additive | |
CN106889331B (en) | A kind of pregnant sow premixed feed | |
CN102626180B (en) | Amino acid chelating compound organic feed additive and production method thereof | |
CN100429991C (en) | Feed for weaned piglet | |
CN101491306B (en) | Layer feed containing wooden fish stone | |
CN107149046B (en) | Functional composite dietary fiber, preparation method and application | |
CN102018129A (en) | Health-care carp feed and preparation method thereof | |
CN108541818A (en) | A kind of artificial breast nutritional formula milk powder feed | |
CN107736492A (en) | A kind of black laying cycle of laying hens feed of new poplar and method for breeding | |
CN103564262B (en) | Hog grower feed | |
CN106260788A (en) | A kind of Micropterus salmonoides premix material | |
CN109170244A (en) | A kind of resisting stress ruminant feed and preparation method thereof | |
CN102125177B (en) | Pellet feed for piglets | |
CN102018133A (en) | Carp feed and preparation method thereof | |
CN105613972A (en) | Vitamin B2 enriched egg production method | |
CN106577513A (en) | Feeding method for improving meat quality of duck at later stage | |
CN102018123A (en) | Freshwater fish feed and preparation method thereof | |
CN105053586A (en) | Multi-functional feed nutrient additive for minks during winter hair growth period and application of multi-functional feed nutrient additive | |
CN104719681A (en) | Milk-replacing compound feed for foxes or raccoon dogs | |
CN110169493A (en) | A kind of feed for increasing yolk color grade and improving laying rate of laying hen | |
CN105053645A (en) | Method for producing feed for Rizhao ma chicken at egg producing period | |
CN115886148A (en) | Preparation method and application of fermented selenium-rich chicken feed added with pine needle powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121114 |
|
CF01 | Termination of patent right due to non-payment of annual fee |